Last reviewed · How we verify

NCT06687460

Distal Nerve Electrical Stimulation for Neuromuscular Reinnervation

ENROLLING BY INVITATION NA Last updated 15 April 2026
What this trial tests

NA trial testing Brief electrical stimulation in Electrical Stimulation in 21 participants. Enrolling by invitation.

Timeline
12 September 2024
Primary endpoint
31 December 2026
31 December 2027

Quick facts

Lead sponsorNational Cheng-Kung University Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment21
Start date12 September 2024
Primary completion31 December 2026
Estimated completion31 December 2027
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Cheng-Kung University Hospital

Who can join

18 and older, any sex, with Electrical Stimulation or Peripheral Nerve Regeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the process of nerve microsurgical reconstruction, 30 minutes of electrical stimulation is applied to the distal end of the damaged nerve to assess its potential benefits for nerve regeneration, functional recovery, slowing down the degeneration at the neuromuscular junction, and preventing muscle atrophy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Electrical Stimulation

Currently open trials in the same condition.

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06687460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing